JI LIN AO DONG released its performance for the first three quarters, with a net profit attributable to the parent company of 2.26 billion yuan, a year-on-year increase of 81.70%Zhitong·Oct 30, 2025 at 12:15 PM000623-1.19%
JI LIN AO DONG: The hydrochloride naloxone injection has passed the consistency evaluation of quality and efficacy for generic drugsZhitong·Oct 20, 2025 at 07:44 AM000623-1.19%
The traditional Chinese medicine concept continues to rise, WBDE hits the limit up, Honz, TMSP, Zhenbao Island, JI LIN AO DONG and others follow suitZhitong·Oct 10, 2025 at 02:31 AM002082-3.46%300086-2.26%
JI LIN AO DONG's subsidiary has obtained the registration certificate for Shengxian Tang granulesZhitong·Sep 19, 2025 at 10:12 AM000623-1.19%
JI LIN AO DONG shareholder Jincheng Company handles share pledge and release of pledgeZhitong·Sep 10, 2025 at 08:56 AM600999-0.38%06099-1.37%
JI LIN AO DONG: The solution for nebulized inhalation of terbutaline sulfate has completed drug registrationZhitong·Sep 5, 2025 at 07:55 AM000623-1.19%
JI LIN AO DONG released its performance for the first half of the year, with a net profit attributable to the parent company of 1.282 billion yuan, an increase of 138.44%Zhitong·Aug 29, 2025 at 11:11 AM000623-1.19%
Some traditional Chinese medicine stocks saw their net profits double year-on-year in the first half of the yearZhitong·Aug 1, 2025 at 02:26 PM600671-1.81%600329-0.33%
JI LIN AO DONG: The holding subsidiary has obtained 25 registration certificates for the listing of traditional Chinese medicine formula granulesZhitong·Jun 3, 2025 at 07:58 AM000623-1.19%
JI LIN AO DONG released its first-quarter performance, with a net profit attributable to the parent company of 517 million yuan, a year-on-year increase of 259.75%Zhitong·Apr 29, 2025 at 10:51 AM000623-1.19%
JILIN AODONG released its 2024 annual performance, with a net profit attributable to the parent company of 1.551 billion yuan, a year-on-year increase of 6.27%Zhitong·Apr 22, 2025 at 12:34 PM000623-1.19%
JILIN AODONG: The holding subsidiary has received the approval notice for the supplementary drug applicationZhitong·Apr 10, 2025 at 09:35 AM000623-1.19%
JILIN AODONG: Polyvinyl Alcohol Eye Drops Obtains Drug Registration CertificateZhitong·Mar 21, 2025 at 07:53 AM000623-1.19%
JILIN AODONG: Yanbian Pharmaceutical passed the drug GMP compliance inspectionZhitong·Feb 10, 2025 at 09:21 AM000623-1.19%
JILIN AODONG has completed the repurchase, with a total expenditure of 420 million yuan to repurchase 1.97% of its sharesZhitong·Feb 10, 2025 at 09:17 AM000623-1.19%
